Sylvie Freeman
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 55
- Hematopoietic Stem Cell Transplantation 12
- Multiple Myeloma Research and Treatments 7
- Chronic Myeloid Leukemia Treatments 7
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Immunology top 5%
- Immunology and Allergy top 5%
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 10
- Retinoids in leukemia and cellular processes 8
-
- Acute Lymphoblastic Leukemia research 17
- Co-authors
- David GrimwadePaul R. CrockerSørge KelmNigel H. RussellAlan K. BurnettRobert K. HillsFarhad RavandiRoland B. Walter
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Sylvie Freeman
70 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 2.0k
- Genetics 490
- Immunology 840
- Immunology and Allergy 192
- Molecular Biology 1.5k
Countries citing papers authored by Sylvie Freeman
This map shows the geographic impact of Sylvie Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Freeman more than expected).
Fields of papers citing papers by Sylvie Freeman
This network shows the impact of papers produced by Sylvie Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Freeman. The network helps show where Sylvie Freeman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sylvie Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 33 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 21 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 12 | |
| 12 | 2020 | 19 | |
| 13 | 2019 | 17 | |
| 14 | 2016 | 17 | |
| 15 | COMBINED ANALYSES OF ROS, CELL CYCLE AND IMMUNOPHENOTYPE SHOWS THAT NORMAL HEMATOPOIETIC PROGENITOR SUBSETS HAVE A DIFFERENTIAL ROS PROFILE THAT IS LOST IN ACUTE MYELOID LEUKEMIA | 2013 | 1 |
| 16 | 2012 | 19 | |
| 17 | MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDY | 2011 | 1 |
| 18 | 2011 | 31 | |
| 19 | 2008 | 49 | |
| 20 | 1995 | 89 |
About Sylvie Freeman
Sylvie Freeman is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 73 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (55 papers), Acute Lymphoblastic Leukemia research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Hematopoietic Stem Cell Transplantation (12 papers), Glycosylation and Glycoproteins Research (10 papers), Retinoids in leukemia and cellular processes (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (2.0k citations), Genetics (490 citations) and Immunology (840 citations). Sylvie Freeman has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include David Grimwade, Paul R. Crocker, Sørge Kelm, Nigel H. Russell, Alan K. Burnett, Robert K. Hills, Farhad Ravandi, Roland B. Walter, Andrew H. Wei and Harry P. Erba. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Blood Advances and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.